Full Press Release Details
Lexicon Pharmaceuticals Announces Departure of President and Chief Operating Officer.
LXRX
Lexicon Pharmaceuticals Announces Departure of President and Chief Operating Officer
Key Takeaway: Lexicon Pharmaceuticals Announces Departure of President and Chief Operating Officer
Price reaction · baseline $1.7 (2024-09-13 close) · clean, no other LXRX news in the window
day 0 close · peak
-4.1%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+111%
120-day peak, hindsight
Typical move
11%
average across 13 past catalysts
Cash runway
~61 mo
Minimal dilution risk
Lead asset
Sotagliflozin
Phase 3 · Type 1 Diabetes Mellitus